Department of Physiotherapy and Rehabilitation, Gazi University , Ankara, Turkey.
Department of Hematology, Bone Marrow Transplantation Unit, Hospital of Bahçelievler Medical Park , Istanbul, Turkey.
Physiother Theory Pract. 2021 Jan;37(1):52-63. doi: 10.1080/09593985.2019.1594473. Epub 2019 Apr 8.
: A limited number of studies have reported impairments in physical activity, exercise capacity and quality of life (QOL) in allogeneic hematopoietic stem cell transplantation (allogeneic-HSCT) recipients. We aimed to compare dyspnea, exercise capacity, physical activity and QOL in allogeneic-HSCT recipients with age-gender matched healthy individuals, since this has not been investigated hitherto. : A total of 80 allogeneic-HSCT recipients (>100 days status post-transplantation) (38.88 ± 13.25 years) and 60 healthy individuals (35.92 ± 10.83 years) were compared. Exercise capacity [6-minute walk test (6-MWT)], physical activity level (total and active energy expenditure, moderate and severe physical activity duration, number of steps, average metabolic equivalent, lying down and sleeping duration) [metabolic holter], QOL [European Organization for Research and Treatment of Cancer QOL Questionnaire (EORTCQOL)], dyspnea [Modified Medical Research Council Dyspnea scale] and pulmonary functions [spirometry] were evaluated. Clinical trials #NCT03606005. : Six-MWT distance, energy expenditure, physical activity duration, number of steps, average metabolic equivalent, global health status, functional and social function subscales of EORTCQOL were significantly lower in recipients compared with controls; dyspnea score, lying down, sleep durations, symptom and fatigue subscales of EORTCQOL were significantly higher in recipients compared with controls ( < 0.05). : Dyspnea during daily living activities, exercise capacity, physical activity level and QOL are considerably impaired in allogeneic-HSCT recipients during post-engraftment period. To improve impaired outcomes, allogeneic-HSCT recipients should be oriented to cardiopulmonary rehabilitation programs.
在异基因造血干细胞移植(allogeneic-HSCT)受者中,已有少数研究报告称其存在体力活动、运动能力和生活质量(QOL)受损的情况。我们旨在比较异基因-HSCT 受者与年龄和性别匹配的健康个体之间的呼吸困难、运动能力、体力活动和 QOL,因为这一点迄今尚未得到研究。
共有 80 名异基因-HSCT 受者(移植后>100 天)(38.88±13.25 岁)和 60 名健康个体(35.92±10.83 岁)进行了比较。运动能力[6 分钟步行测试(6-MWT)]、体力活动水平(总能量和活跃能量消耗、中等和剧烈体力活动持续时间、步数、平均代谢当量、躺下和睡眠时间)[代谢 Holter]、QOL[欧洲癌症研究与治疗组织生活质量问卷(EORTCQOL)]、呼吸困难[改良的医学研究委员会呼吸困难量表]和肺功能[肺活量测定]进行了评估。临床试验 #NCT03606005。
与对照组相比,受者的 6-MWT 距离、能量消耗、体力活动持续时间、步数、平均代谢当量、总体健康状况、EORTCQOL 的功能和社会功能子量表显著降低;受者的呼吸困难评分、躺下时间、睡眠时间、症状和疲劳子量表均显著高于对照组(<0.05)。
在移植后阶段,异基因-HSCT 受者在日常活动时出现呼吸困难、运动能力、体力活动水平和 QOL 明显受损。为改善受损的结果,应向异基因-HSCT 受者介绍心肺康复方案。